| Full text | |
| Author(s): |
Fagundes, Gustavo F. C.
;
Almeida, Madson Q.
Total Authors: 2
|
| Document type: | Journal article |
| Source: | JOURNAL OF THE ENDOCRINE SOCIETY; v. 8, n. 6, p. 12-pg., 2024-04-06. |
| Abstract | |
Pheochromocytomas and paragangliomas (PPGLs), rare neuroendocrine tumors arising from chromaffin cells, present a significant diagnostic challenge due to their clinical rarity and polymorphic symptomatology. The clinical cases demonstrate the importance of an integrated approach that combines clinical assessment, biochemical testing, and imaging to distinguish PPGLs from mimicking conditions, such as obstructive sleep apnea and interfering medication effects, which can lead to false-positive biochemical results. Although a rare condition, false-negative metanephrine levels can occur in pheochromocytomas, but imaging findings can give some clues and increase suspicion for a pheochromocytoma diagnosis. This expert endocrine consult underscores the critical role of evaluating preanalytical conditions and pretest probability in the biochemical diagnosis of PPGLs. Moreover, a careful differentiation of PPGLs from similar conditions and careful selection and interpretation of diagnostic tests, with focus on understanding and reducing false positives to enhance diagnostic accuracy and patient outcomes, is crucial. (AU) | |
| FAPESP's process: | 19/15873-6 - Investigation of new genetic, clinical and pathological aspects of endocrine arterial hypertension |
| Grantee: | Madson Queiroz Almeida |
| Support Opportunities: | Research Projects - Thematic Grants |